Slovia Pharmaceuticals Private Limited - Company Profile

It is a manufacturing private limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Slovia Pharmaceuticals Private Limited

Slovia Pharmaceuticals Private Limited, a struck off private limited company, was established on 24 May 2011 in Mumbai, Maharashtra, India. Engaging in other within the manufacturing sector, it holds CIN: U36912MH2011PTC217795. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Gordon Paul Noronha (Director), Ruark Gordon Denoronha (Director). Past directors included Diven Vijaykumar Narsian. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at Sharaf Manzil,3Rd,Flr,650 J.S.S.Rd,Marine Lines(E) 2Nd Dhobitalao, Mumbai, Maharashtra, 400002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36912MH2011PTC217795

  • Registration Number

    217795

  • Incorporation Date

    24 May 2011

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 14 Year, 9 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Slovia Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Slovia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Slovia Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Gordon Paul Noronha Director 24 May 2011 Current
Ruark Gordon Denoronha Director 15 Feb 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Feb 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Slovia Pharmaceuticals.

Enhance accessibility to Slovia Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Slovia Pharmaceuticals revenue growth over time
Slovia Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Slovia Pharmaceuticals?

Unlock access to Slovia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Slovia Pharmaceuticals?

Unlock and access historical data on people associated with Slovia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Slovia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Slovia Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Slovia Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Ruark Gordon Denoronha was appointed as a Director was appointed as a Director on 15 Feb 2016 & has been associated with this company since 10 years 26 days . was documented.

  • Annual General Meeting

    Progress on Slovia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Slovia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai. was completed.

  • Director Appointment

    Gordon Paul Noronha was appointed as a Director was appointed as a Director on 24 May 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.

  • Company Incorporation

    Slovia Pharmaceuticals Private Limited was registered on 24 May 2011 with Roc Mumbai & aged 14 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Slovia Pharmaceuticals Private Limited?

The CIN of Slovia Pharmaceuticals Private Limited is U36912MH2011PTC217795.

Where is Slovia Pharmaceuticals Private Limited headquartered?

Slovia Pharmaceuticals Private Limited is headquartered at Sharaf Manzil,3Rd,Flr,650 J.S.S.Rd,Marine Lines(E) 2Nd Dhobitalao, Mumbai, Maharashtra, 400002.

When was Slovia Pharmaceuticals Private Limited incorporated?

Slovia Pharmaceuticals Private Limited was incorporated on 24 May 2011.

Who are the current directors of Slovia Pharmaceuticals Private Limited?

The current directors of Slovia Pharmaceuticals Private Limited are

What is the primary industry of Slovia Pharmaceuticals Private Limited?

The primary industry of Slovia Pharmaceuticals Private Limited is Manufacturing.

Is Slovia Pharmaceuticals Private Limited a listed company?

Slovia Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Slovia Pharmaceuticals Private Limited?

The authorized capital of Slovia Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available